INCB059872
Product Specifications
UNSPSC Description
INCB059872 is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor. INCB059872 can be used for the research of myeloid leukemia[1].
Target Antigen
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/incb059872.html
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
OC(C1(CCC1)CN2CCC(COC)(CC2)CN[C@H]3[C@@](C4=CC=CC=C4)([H])C3)=O
Molecular Weight
386.53
References & Citations
[1] Johnston G, et al. Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemia. Gene. 2020;752:144758.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-141677/INCB059872-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-141677/INCB059872-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1802909-49-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6304489-01 0.1 mL
GRIP2, ID (GRIP2, KIAA1719, Glutamate receptor-interacting protein 2) (MaxLight 650)
Ask
View Details MBS6304489-02 5x 0.1 mL
GRIP2, ID (GRIP2, KIAA1719, Glutamate receptor-interacting protein 2) (MaxLight 650)
Ask
View Details 
